Schneeberger Daniel
- SEC CIK
- 0001861120
Latest role at each company
- INM InMed Pharmaceuticals Inc.10% Owneras of Sep 16, 2026
- TENX TENAX THERAPEUTICS, INC.10% Owneras of Sep 8, 2026
- NXTC NextCure, Inc.10% Owneras of Aug 3, 2026
- RLYB Rallybio Corp10% Owneras of May 20, 2026
- KROS Keros Therapeutics, Inc.10% Owneras of Oct 15, 2025
Trades
Every Form 4 that lists Schneeberger Daniel as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| INMInMed Pharmaceuticals Inc. | Sep 16, 20266:58 PM ET | Sep 14 – Sep 16, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Shares | +91.1K | $1.2961 | +$118.08K | 892.1K | +11.4% | SEC |
| TENXTENAX THERAPEUTICS, INC. | Sep 8, 20265:16 PM ET | Sep 3, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Stock | +900K | $1.7824 | +$1.6M | 6.52M | +16.0% | SEC |
| TENXTENAX THERAPEUTICS, INC. | Sep 2, 20265:52 PM ET | Aug 31 – Sep 2, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Stock | +770.33K | $1.7937 | +$1.38M | 5.62M | +15.9% | SEC |
| TENXTENAX THERAPEUTICS, INC. | Aug 24, 20266:12 PM ET | Aug 20 – Aug 24, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Stock | +1.03M | $1.7684 | +$1.81M | 4.85M | +26.8% | SEC |
| NXTCNextCure, Inc. | Aug 3, 20265:53 PM ET | Jul 30 – Jul 31, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Stock | +329.15K | $4.9342 | +$1.62M | 722.42K | +83.7% | SEC |
| NXTCNextCure, Inc. | Jul 29, 20266:18 PM ET | Jul 27 – Jul 29, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Stock | +17.61K | $4.9814 | +$87.71K | 393.27K | +4.7% | SEC |
| INMInMed Pharmaceuticals Inc. | Jul 17, 20267:29 PM ET | Jul 15, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Shares | +1K | $1.555 | +$1.56K | 801K | +0.1% | SEC |
| INMInMed Pharmaceuticals Inc. | May 21, 20265:08 PM ET | May 19, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Shares | +468.55K | $1.54 | +$721.55K | 800K | +141.4% | SEC |
| RLYBRallybio Corp | May 20, 20268:45 PM ET | May 18 – May 19, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Stock | +16.21K | $13.9776 | +$226.56K | 926.35K | +1.8% | SEC |
| RLYBRallybio Corp | May 15, 20268:49 PM ET | May 13 – May 15, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Stock | +79.56K | $13.9893 | +$1.11M | 910.14K | +9.6% | SEC |
| RLYBRallybio Corp | May 13, 20269:22 PM ET | May 11 – May 12, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Stock | +50.8K | $13.9971 | +$711.05K | 830.58K | +6.5% | SEC |
| RLYBRallybio Corp | May 6, 20269:32 PM ET | May 4 – May 5, 2026 | Schneeberger Daniel and 1 other10% Owner | PPurchaseCommon Stock | +155.91K | $13.9743 | +$2.18M | 779.78K | +25.0% | SEC |
| KROSKeros Therapeutics, Inc. | Oct 15, 20251:24 PM ET | Oct 15, 2025 | ADAR1 Partners, LP and 3 others10% Owner | SSaleCommon Stock | −5.39M | $17.75 | −$95.66M | 0 | −100.0% | SEC |
| KROSKeros Therapeutics, Inc. | Apr 11, 20259:57 PM ET | Apr 9, 2025 | ADAR1 Partners, LP and 3 others10% Owner | PPurchaseCommon Stock | +934.26K | $10.1305 | +$9.46M | 4.39M | +27.0% | SEC |